Loading…

Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote

Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five majo...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiology 2017-07, Vol.70 (1), p.74-79
Main Authors: Fujii, Yusuke, MD, Matsumoto, Yuichi, MD, Hayashi, Kenshi, MD, PhD, FJCC, Ding, Wei-Guang, MD, PhD, Tomita, Yukinori, MD, Fukumoto, Daisuke, MD, Wada, Yuko, MD, Ichikawa, Mari, MD, Sonoda, Keiko, MD, Ozawa, Junichi, MD, Makiyama, Takeru, MD, PhD, Ohno, Seiko, MD, PhD, Yamagishi, Masakazu, MD, PhD, FJCC, Matsuura, Hiroshi, MD, PhD, Horie, Minoru, MD, PhD, Itoh, Hideki, MD, PhD, FJCC
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913
cites cdi_FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913
container_end_page 79
container_issue 1
container_start_page 74
container_title Journal of cardiology
container_volume 70
creator Fujii, Yusuke, MD
Matsumoto, Yuichi, MD
Hayashi, Kenshi, MD, PhD, FJCC
Ding, Wei-Guang, MD, PhD
Tomita, Yukinori, MD
Fukumoto, Daisuke, MD
Wada, Yuko, MD
Ichikawa, Mari, MD
Sonoda, Keiko, MD
Ozawa, Junichi, MD
Makiyama, Takeru, MD, PhD
Ohno, Seiko, MD, PhD
Yamagishi, Masakazu, MD, PhD, FJCC
Matsuura, Hiroshi, MD, PhD
Horie, Minoru, MD, PhD
Itoh, Hideki, MD, PhD, FJCC
description Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five major genes: KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNE2 and 389 probands were found to be mutation carriers. We analyzed the clinical phenotypes of p.His492Tyr carriers in KCNH2. Results Heterozygous p.His492Tyr variant was identified in 10 LQTS families. Six probands (mean age, 26 ± 23 years) carried another mutation, and two of six had syncope associated with emotional stress or telephone ringing. The remaining four probands were significantly older at diagnosis (mean age, 42 ± 33 years) and carried no other compound mutations. All the four probands had fatal arrhythmic events in the presence of additional precipitating factors such as culprit drugs in 2, hypokalemia in 1, and bradycardia in 1. The QTc interval of carriers with p.His492Tyr alone was 445 ± 10 ms and significantly shorter than that in double mutation carriers (481 ± 40 ms, p = 0.041). Conclusions KCNH2 p.His492Tyr variant presented Romano–Ward syndrome in the presence of another mutation and heterozygous carriers had mild phenotypes while even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest “latent” form of p.His492Tyr heterozygous carriers.
doi_str_mv 10.1016/j.jjcc.2016.09.010
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837026805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0914508716302192</els_id><sourcerecordid>1837026805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913</originalsourceid><addsrcrecordid>eNp9ks-K1TAUxosoznX0BVxIlm5aT_oviYgwXNQRB0UdcRnS5PSa2iZ3knagrnwH176cT2LLvc5CxFUO4fu-wzm_kyQPKWQUaP2ky7pO6yxf6gxEBhRuJRvKWZ2WrOC3kw0IWqYVcHaS3IuxA6hB8PpucpIzTuuCik3yc-vdGGwzjdY74luiyJvt2_OcXKtglRuJdWSHzo_zHg3pvduR95ckzs4EP-BT8sEPyvlf3398VsHc_JPJGQzE-KnpkQzTqNb4SJQzROmryYZ_hB1NX3DE4L_NOz_i_eROq_qID47vafLp5YvL7Xl68e7V6-3ZRaqrshpTXrVMUcVq2tSlElDwAhqgJeeIhWiBa8ZAtE1RgQbWGA261qyGFgukTNDiNHl8yN0HfzVhHOVgo8a-Vw79FCXlBYO85lAt0vwg1cHHGLCV-2AHFWZJQa5YZCdXLHLFIkHIBctienTMn5oBzY3lD4dF8OwgwGXKa4tBRm3RaTTLqvQojbf_z3_-l1331lmt-q84Y-z8FNyyP0llzCXIj-thrHexNIecirz4DeZstj4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1837026805</pqid></control><display><type>article</type><title>Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote</title><source>Elsevier</source><creator>Fujii, Yusuke, MD ; Matsumoto, Yuichi, MD ; Hayashi, Kenshi, MD, PhD, FJCC ; Ding, Wei-Guang, MD, PhD ; Tomita, Yukinori, MD ; Fukumoto, Daisuke, MD ; Wada, Yuko, MD ; Ichikawa, Mari, MD ; Sonoda, Keiko, MD ; Ozawa, Junichi, MD ; Makiyama, Takeru, MD, PhD ; Ohno, Seiko, MD, PhD ; Yamagishi, Masakazu, MD, PhD, FJCC ; Matsuura, Hiroshi, MD, PhD ; Horie, Minoru, MD, PhD ; Itoh, Hideki, MD, PhD, FJCC</creator><creatorcontrib>Fujii, Yusuke, MD ; Matsumoto, Yuichi, MD ; Hayashi, Kenshi, MD, PhD, FJCC ; Ding, Wei-Guang, MD, PhD ; Tomita, Yukinori, MD ; Fukumoto, Daisuke, MD ; Wada, Yuko, MD ; Ichikawa, Mari, MD ; Sonoda, Keiko, MD ; Ozawa, Junichi, MD ; Makiyama, Takeru, MD, PhD ; Ohno, Seiko, MD, PhD ; Yamagishi, Masakazu, MD, PhD, FJCC ; Matsuura, Hiroshi, MD, PhD ; Horie, Minoru, MD, PhD ; Itoh, Hideki, MD, PhD, FJCC</creatorcontrib><description>Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five major genes: KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNE2 and 389 probands were found to be mutation carriers. We analyzed the clinical phenotypes of p.His492Tyr carriers in KCNH2. Results Heterozygous p.His492Tyr variant was identified in 10 LQTS families. Six probands (mean age, 26 ± 23 years) carried another mutation, and two of six had syncope associated with emotional stress or telephone ringing. The remaining four probands were significantly older at diagnosis (mean age, 42 ± 33 years) and carried no other compound mutations. All the four probands had fatal arrhythmic events in the presence of additional precipitating factors such as culprit drugs in 2, hypokalemia in 1, and bradycardia in 1. The QTc interval of carriers with p.His492Tyr alone was 445 ± 10 ms and significantly shorter than that in double mutation carriers (481 ± 40 ms, p = 0.041). Conclusions KCNH2 p.His492Tyr variant presented Romano–Ward syndrome in the presence of another mutation and heterozygous carriers had mild phenotypes while even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest “latent” form of p.His492Tyr heterozygous carriers.</description><identifier>ISSN: 0914-5087</identifier><identifier>EISSN: 1876-4738</identifier><identifier>DOI: 10.1016/j.jjcc.2016.09.010</identifier><identifier>PMID: 27816319</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Acquired long QT syndrome ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Bradycardia-induced long QT syndrome ; Cardiovascular ; Child ; Child, Preschool ; Drug-induced long QT syndrome ; Electrocardiography ; ERG1 Potassium Channel - genetics ; Female ; Genetic Testing ; Genotype ; Heterozygote ; Humans ; Hypokalemia - genetics ; Hypokalemia-induced long QT syndrome ; KCNH2 ; Long QT Syndrome - genetics ; Male ; Middle Aged ; Mutation ; Phenotype ; Young Adult</subject><ispartof>Journal of cardiology, 2017-07, Vol.70 (1), p.74-79</ispartof><rights>Japanese College of Cardiology</rights><rights>2016 Japanese College of Cardiology</rights><rights>Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913</citedby><cites>FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913</cites><orcidid>0000-0003-3572-0836</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27816319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fujii, Yusuke, MD</creatorcontrib><creatorcontrib>Matsumoto, Yuichi, MD</creatorcontrib><creatorcontrib>Hayashi, Kenshi, MD, PhD, FJCC</creatorcontrib><creatorcontrib>Ding, Wei-Guang, MD, PhD</creatorcontrib><creatorcontrib>Tomita, Yukinori, MD</creatorcontrib><creatorcontrib>Fukumoto, Daisuke, MD</creatorcontrib><creatorcontrib>Wada, Yuko, MD</creatorcontrib><creatorcontrib>Ichikawa, Mari, MD</creatorcontrib><creatorcontrib>Sonoda, Keiko, MD</creatorcontrib><creatorcontrib>Ozawa, Junichi, MD</creatorcontrib><creatorcontrib>Makiyama, Takeru, MD, PhD</creatorcontrib><creatorcontrib>Ohno, Seiko, MD, PhD</creatorcontrib><creatorcontrib>Yamagishi, Masakazu, MD, PhD, FJCC</creatorcontrib><creatorcontrib>Matsuura, Hiroshi, MD, PhD</creatorcontrib><creatorcontrib>Horie, Minoru, MD, PhD</creatorcontrib><creatorcontrib>Itoh, Hideki, MD, PhD, FJCC</creatorcontrib><title>Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote</title><title>Journal of cardiology</title><addtitle>J Cardiol</addtitle><description>Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five major genes: KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNE2 and 389 probands were found to be mutation carriers. We analyzed the clinical phenotypes of p.His492Tyr carriers in KCNH2. Results Heterozygous p.His492Tyr variant was identified in 10 LQTS families. Six probands (mean age, 26 ± 23 years) carried another mutation, and two of six had syncope associated with emotional stress or telephone ringing. The remaining four probands were significantly older at diagnosis (mean age, 42 ± 33 years) and carried no other compound mutations. All the four probands had fatal arrhythmic events in the presence of additional precipitating factors such as culprit drugs in 2, hypokalemia in 1, and bradycardia in 1. The QTc interval of carriers with p.His492Tyr alone was 445 ± 10 ms and significantly shorter than that in double mutation carriers (481 ± 40 ms, p = 0.041). Conclusions KCNH2 p.His492Tyr variant presented Romano–Ward syndrome in the presence of another mutation and heterozygous carriers had mild phenotypes while even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest “latent” form of p.His492Tyr heterozygous carriers.</description><subject>Acquired long QT syndrome</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bradycardia-induced long QT syndrome</subject><subject>Cardiovascular</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Drug-induced long QT syndrome</subject><subject>Electrocardiography</subject><subject>ERG1 Potassium Channel - genetics</subject><subject>Female</subject><subject>Genetic Testing</subject><subject>Genotype</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Hypokalemia - genetics</subject><subject>Hypokalemia-induced long QT syndrome</subject><subject>KCNH2</subject><subject>Long QT Syndrome - genetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Phenotype</subject><subject>Young Adult</subject><issn>0914-5087</issn><issn>1876-4738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9ks-K1TAUxosoznX0BVxIlm5aT_oviYgwXNQRB0UdcRnS5PSa2iZ3knagrnwH176cT2LLvc5CxFUO4fu-wzm_kyQPKWQUaP2ky7pO6yxf6gxEBhRuJRvKWZ2WrOC3kw0IWqYVcHaS3IuxA6hB8PpucpIzTuuCik3yc-vdGGwzjdY74luiyJvt2_OcXKtglRuJdWSHzo_zHg3pvduR95ckzs4EP-BT8sEPyvlf3398VsHc_JPJGQzE-KnpkQzTqNb4SJQzROmryYZ_hB1NX3DE4L_NOz_i_eROq_qID47vafLp5YvL7Xl68e7V6-3ZRaqrshpTXrVMUcVq2tSlElDwAhqgJeeIhWiBa8ZAtE1RgQbWGA261qyGFgukTNDiNHl8yN0HfzVhHOVgo8a-Vw79FCXlBYO85lAt0vwg1cHHGLCV-2AHFWZJQa5YZCdXLHLFIkHIBctienTMn5oBzY3lD4dF8OwgwGXKa4tBRm3RaTTLqvQojbf_z3_-l1331lmt-q84Y-z8FNyyP0llzCXIj-thrHexNIecirz4DeZstj4</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Fujii, Yusuke, MD</creator><creator>Matsumoto, Yuichi, MD</creator><creator>Hayashi, Kenshi, MD, PhD, FJCC</creator><creator>Ding, Wei-Guang, MD, PhD</creator><creator>Tomita, Yukinori, MD</creator><creator>Fukumoto, Daisuke, MD</creator><creator>Wada, Yuko, MD</creator><creator>Ichikawa, Mari, MD</creator><creator>Sonoda, Keiko, MD</creator><creator>Ozawa, Junichi, MD</creator><creator>Makiyama, Takeru, MD, PhD</creator><creator>Ohno, Seiko, MD, PhD</creator><creator>Yamagishi, Masakazu, MD, PhD, FJCC</creator><creator>Matsuura, Hiroshi, MD, PhD</creator><creator>Horie, Minoru, MD, PhD</creator><creator>Itoh, Hideki, MD, PhD, FJCC</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3572-0836</orcidid></search><sort><creationdate>20170701</creationdate><title>Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote</title><author>Fujii, Yusuke, MD ; Matsumoto, Yuichi, MD ; Hayashi, Kenshi, MD, PhD, FJCC ; Ding, Wei-Guang, MD, PhD ; Tomita, Yukinori, MD ; Fukumoto, Daisuke, MD ; Wada, Yuko, MD ; Ichikawa, Mari, MD ; Sonoda, Keiko, MD ; Ozawa, Junichi, MD ; Makiyama, Takeru, MD, PhD ; Ohno, Seiko, MD, PhD ; Yamagishi, Masakazu, MD, PhD, FJCC ; Matsuura, Hiroshi, MD, PhD ; Horie, Minoru, MD, PhD ; Itoh, Hideki, MD, PhD, FJCC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acquired long QT syndrome</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bradycardia-induced long QT syndrome</topic><topic>Cardiovascular</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Drug-induced long QT syndrome</topic><topic>Electrocardiography</topic><topic>ERG1 Potassium Channel - genetics</topic><topic>Female</topic><topic>Genetic Testing</topic><topic>Genotype</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Hypokalemia - genetics</topic><topic>Hypokalemia-induced long QT syndrome</topic><topic>KCNH2</topic><topic>Long QT Syndrome - genetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Phenotype</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fujii, Yusuke, MD</creatorcontrib><creatorcontrib>Matsumoto, Yuichi, MD</creatorcontrib><creatorcontrib>Hayashi, Kenshi, MD, PhD, FJCC</creatorcontrib><creatorcontrib>Ding, Wei-Guang, MD, PhD</creatorcontrib><creatorcontrib>Tomita, Yukinori, MD</creatorcontrib><creatorcontrib>Fukumoto, Daisuke, MD</creatorcontrib><creatorcontrib>Wada, Yuko, MD</creatorcontrib><creatorcontrib>Ichikawa, Mari, MD</creatorcontrib><creatorcontrib>Sonoda, Keiko, MD</creatorcontrib><creatorcontrib>Ozawa, Junichi, MD</creatorcontrib><creatorcontrib>Makiyama, Takeru, MD, PhD</creatorcontrib><creatorcontrib>Ohno, Seiko, MD, PhD</creatorcontrib><creatorcontrib>Yamagishi, Masakazu, MD, PhD, FJCC</creatorcontrib><creatorcontrib>Matsuura, Hiroshi, MD, PhD</creatorcontrib><creatorcontrib>Horie, Minoru, MD, PhD</creatorcontrib><creatorcontrib>Itoh, Hideki, MD, PhD, FJCC</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fujii, Yusuke, MD</au><au>Matsumoto, Yuichi, MD</au><au>Hayashi, Kenshi, MD, PhD, FJCC</au><au>Ding, Wei-Guang, MD, PhD</au><au>Tomita, Yukinori, MD</au><au>Fukumoto, Daisuke, MD</au><au>Wada, Yuko, MD</au><au>Ichikawa, Mari, MD</au><au>Sonoda, Keiko, MD</au><au>Ozawa, Junichi, MD</au><au>Makiyama, Takeru, MD, PhD</au><au>Ohno, Seiko, MD, PhD</au><au>Yamagishi, Masakazu, MD, PhD, FJCC</au><au>Matsuura, Hiroshi, MD, PhD</au><au>Horie, Minoru, MD, PhD</au><au>Itoh, Hideki, MD, PhD, FJCC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote</atitle><jtitle>Journal of cardiology</jtitle><addtitle>J Cardiol</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>70</volume><issue>1</issue><spage>74</spage><epage>79</epage><pages>74-79</pages><issn>0914-5087</issn><eissn>1876-4738</eissn><abstract>Abstract Background Long QT syndrome (LQTS) presents two clinical phenotypes, congenital and acquired forms. This study aims to evaluate the genetic contribution of a KCNH2 variant for the two LQTS phenotypes. Methods From 1996 to 2014, genetic screening for LQTS probands was performed for five major genes: KCNQ1 , KCNH2 , SCN5A , KCNE1 , and KCNE2 and 389 probands were found to be mutation carriers. We analyzed the clinical phenotypes of p.His492Tyr carriers in KCNH2. Results Heterozygous p.His492Tyr variant was identified in 10 LQTS families. Six probands (mean age, 26 ± 23 years) carried another mutation, and two of six had syncope associated with emotional stress or telephone ringing. The remaining four probands were significantly older at diagnosis (mean age, 42 ± 33 years) and carried no other compound mutations. All the four probands had fatal arrhythmic events in the presence of additional precipitating factors such as culprit drugs in 2, hypokalemia in 1, and bradycardia in 1. The QTc interval of carriers with p.His492Tyr alone was 445 ± 10 ms and significantly shorter than that in double mutation carriers (481 ± 40 ms, p = 0.041). Conclusions KCNH2 p.His492Tyr variant presented Romano–Ward syndrome in the presence of another mutation and heterozygous carriers had mild phenotypes while even heterozygous carriers should be cared for not to encounter secondary factors because incidental factors could manifest “latent” form of p.His492Tyr heterozygous carriers.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27816319</pmid><doi>10.1016/j.jjcc.2016.09.010</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3572-0836</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0914-5087
ispartof Journal of cardiology, 2017-07, Vol.70 (1), p.74-79
issn 0914-5087
1876-4738
language eng
recordid cdi_proquest_miscellaneous_1837026805
source Elsevier
subjects Acquired long QT syndrome
Adolescent
Adult
Aged
Aged, 80 and over
Bradycardia-induced long QT syndrome
Cardiovascular
Child
Child, Preschool
Drug-induced long QT syndrome
Electrocardiography
ERG1 Potassium Channel - genetics
Female
Genetic Testing
Genotype
Heterozygote
Humans
Hypokalemia - genetics
Hypokalemia-induced long QT syndrome
KCNH2
Long QT Syndrome - genetics
Male
Middle Aged
Mutation
Phenotype
Young Adult
title Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano–Ward syndrome under double mutations and acquired long QT syndrome under heterozygote
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T00%3A30%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contribution%20of%20a%20KCNH2%20variant%20in%20genotyped%20long%20QT%20syndrome:%20Romano%E2%80%93Ward%20syndrome%20under%20double%20mutations%20and%20acquired%20long%20QT%20syndrome%20under%20heterozygote&rft.jtitle=Journal%20of%20cardiology&rft.au=Fujii,%20Yusuke,%20MD&rft.date=2017-07-01&rft.volume=70&rft.issue=1&rft.spage=74&rft.epage=79&rft.pages=74-79&rft.issn=0914-5087&rft.eissn=1876-4738&rft_id=info:doi/10.1016/j.jjcc.2016.09.010&rft_dat=%3Cproquest_cross%3E1837026805%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c545t-85f7a1a761b64a903830b01488ee39f08c7709fb350c07bdc0c6c760fe3e17913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1837026805&rft_id=info:pmid/27816319&rfr_iscdi=true